November 10, 2025
Eight out of 10 Infants and Newborns in Canada have Access to RSV Prevention with Beyfortus® this Season
November 6, 2025
Rezurock® Now Covered in Quebec for People Living with Chronic Graft-versus-host Disease (GVHD)
November 3, 2025
Dupixent® Approved in Canada as Targeted Therapy for Chronic Spontaneous Urticaria (CSU)
No current content.
